Flowr Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Flowr heeft een totaal eigen vermogen van CA$13.2M en een totale schuld van CA$4.7M, wat de schuld-eigenvermogensverhouding op 35.7% brengt. De totale activa en totale passiva bedragen respectievelijk CA$28.5M en CA$15.3M.

Belangrijke informatie

35.7%

Verhouding schuld/eigen vermogen

CA$4.73m

Schuld

Rente dekkingsratio	n/a
Contant	CA$1.48m
Aandelen	CA$13.24m
Totaal verplichtingen	CA$15.30m
Totaal activa	CA$28.54m

Recente financiële gezondheidsupdates

Recent updates

Flowr's (CVE:FLWR) Stock Price Has Reduced 79% In The Past Year

Jan 18

The Flowr Corporation (CVE:FLWR) Analysts Are More Bearish Than They Used To Be

Nov 26

How Many The Flowr Corporation (CVE:FLWR) Shares Did Insiders Buy, In The Last Year?

Jul 21

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CA$8.8M ) FLWR.H } overtreffen de korte termijn passiva ( CA$6.3M ).

Langlopende schulden: De kortetermijnactiva van FLWR.H ( CA$8.8M ) dekken de langetermijnschulden ( CA$9.0M ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 24.5% ) FLWR.H wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van FLWR.H is de afgelopen 5 jaar gestegen van 0% naar 35.7%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: FLWR.H heeft minder dan een jaar aan cash runway op basis van de huidige vrije kasstroom.

Voorspelling contante baan: FLWR.H heeft minder dan een jaar aan kasmiddelen als de vrije kasstroom blijft dalen met historische percentages van 4.3 % per jaar.

Flowr Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

The Flowr Corporation Requests to Delist from the TSX Venture Exchange

Recent updates

The Flowr Corporation Requests to Delist from the TSX Venture Exchange

Avant Brands K1 Inc. (formerly 1000343100 Ontario Inc.) completed the acquisition of The Flowr Group (Okanagan) Inc. from The Flowr Corporation (TSXV:FLWR.H) for CAD 5.12 million.

1000343100 Ontario Inc. entered into a Stalking Horse Purchase Agreement to acquire The Flowr Group (Okanagan) Inc from The Flowr Corporation (TSXV:FLWR.H) for CAD 0.89 million.

The Flowr Corporation Announces Resignation of Stephen Arbib as Director

The Flowr Corporation Announces the Resignation of Joanne Lee from the Board of Directors

High number of new and inexperienced directors

The Flowr Corporation Announces Management Changes

Hawthorne Canada Limited completed the acquisition of KRS Facility in Kelowna from The Flowr Corporation (TSXV:FLWR).

The Flowr Corporation (TSXV:FLWR) completed the acquisition of KRS Facility in Kelowna for CAD16 million.

The Flowr Corporation Announces Resignation of Noel Biderman as Director

The Flowr Corporation Announces Resignation of Directors

The Flowr Corporation, Annual General Meeting, Sep 07, 2022

The Flowr Corporation Announces Headcount Reduction

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$0.04

High number of new and inexperienced directors

The Flowr Corporation Announces Impairment Charges for the First Quarter Ended March 31, 2022

The Flowr Corporation Announces Impairment Charges for the Fourth Quarter Ended December 31, 2021

Cannahealth Limited completed the acquisition of Holigen Limited from The Flowr Corporation (TSXV:FLWR).

Price target decreased to CA$0.08

High number of new and inexperienced directors

Cannahealth Limited entered into a definitive agreement to acquire Holigen Limited from The Flowr Corporation (TSXV:FLWR) for CAD 34.1 million.

Hawthorne Canada Limited entered into an agreement to acquire KRS Facility in Kelowna from The Flowr Corporation (TSXV:FLWR) for $16 million.

Consensus revenue estimates fall to CA$12.0m

Third quarter 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2021 earnings released: CA$0.02 loss per share (vs CA$0.04 loss in 2Q 2020)

Health Canada Grants a Research License to The Flowr Corporation

The Flowr Corporation announced that it has received CAD 7.014 million in funding

The Flowr Corporation announced that it expects to receive CAD 7.014 million in funding

Price target decreased to CA$0.68

Rodeo Capital Limited entered into an agreement to acquire TCann Pty Ltd. from The Flowr Corporation (TSXV:FLWR) for AUD 0.50 million.

The Flowr Corporation has completed a Composite Units Offering in the amount of CAD 15.3 million.

New 90-day low: CA$0.31

New 90-day high: CA$0.60

The Flowr Corporation Partners with ROSE Lifescience Inc

The Flowr Corporation announced that it expects to receive CAD 1 million in funding

Flowr's (CVE:FLWR) Stock Price Has Reduced 79% In The Past Year

Flowr and Hawthorne Canada Jointly Announce the Completion of the World’S First Cannabis Research and Development Facility of Its Kind

New 90-day low: CA$0.33

The Flowr Corporation Announces CEO Changes

The Flowr Corporation Announces Board Appointment

The Flowr Corporation Announces Strategic Warehousing Agreement with Tilray, Inc

New 90-day low: CA$0.35

Price target lowered to CA$1.15

Analysts lower revenue estimates to CA$9.21m

Third quarter 2020 earnings released: CA$0.07 loss per share

Earnings beat expectations, revenue disappoints

The Flowr Corporation (CVE:FLWR) Analysts Are More Bearish Than They Used To Be

The Flowr Corporation to Report Q3, 2020 Results on Nov 24, 2020

Andrew Teehan to Leave The Flowr Corporation as General Counsel, Effective October 28, 2020

Price target lowered to CA$1.45

New 90-day low: CA$0.39

First half earnings released

Analysts update estimates

The Flowr Corporation to Report Q2, 2020 Results on Aug 26, 2020

New 90-day low - CA$0.50

How Many The Flowr Corporation (CVE:FLWR) Shares Did Insiders Buy, In The Last Year?

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven